Cabaletta Bio, Inc.
NASDAQ:CABA
1.19 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 4.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0.426 | 0.393 | 0.336 | 0.355 | 0.833 | 0 | 2.864 | 0.363 | 0.238 | 0.219 | 0.234 | 0.221 | 0.162 | 0.116 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | -0.426 | -0.393 | 3.674 | -0.355 | -0.833 | 0 | -2.864 | -0.363 | -0.238 | -0.219 | -0.234 | -0.221 | -0.162 | -0.116 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0.916 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 25.532 | 26.29 | 23.427 | 21.954 | 17.405 | 13.787 | 11.797 | 12.435 | 12.4 | 8.216 | 9.514 | 9.17 | 9.919 | 8.169 | 7.85 | 6.556 | 5.775 | 5.65 | 5.331 | 4.62 | 3.026 | 3.22 | 2.664 | 2.761 | 1.239 | 2.589 | 0.32 | 0.32 |
| General & Administrative Expenses
| 8.253 | 6.756 | 6.852 | 6.077 | 5.741 | 4.881 | 4.093 | 4.521 | 3.902 | 3.562 | 3.546 | 3.829 | 3.974 | 3.394 | 3.295 | 3.156 | 3.555 | 2.766 | 2.861 | 3.275 | 2.834 | 1.811 | 1.138 | 1.229 | 0.826 | 0.491 | 0.205 | 0.205 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -0.393 | -0.336 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.253 | 6.756 | 6.852 | 5.684 | 5.405 | 4.881 | 4.093 | 4.521 | 3.902 | 3.562 | 3.546 | 3.829 | 3.974 | 3.394 | 3.295 | 3.156 | 3.555 | 2.766 | 2.861 | 3.275 | 2.834 | 1.811 | 1.138 | 1.229 | 0.826 | 0.491 | 0.205 | 0.205 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.244 | 0 | 0 |
| Operating Expenses
| 33.785 | 33.046 | 30.279 | 27.638 | 22.81 | 18.668 | 15.89 | 16.956 | 16.302 | 11.778 | 13.06 | 12.999 | 13.893 | 11.563 | 11.145 | 9.712 | 9.33 | 8.416 | 8.192 | 7.895 | 5.86 | 5.031 | 3.802 | 3.99 | 2.065 | 3.08 | 0.524 | 0.524 |
| Operating Income
| -33.785 | -33.046 | -30.279 | -28.031 | -23.146 | -18.668 | -15.89 | -16.956 | -16.302 | -11.778 | -13.06 | -12.999 | -13.893 | -11.563 | -11.145 | -9.712 | -9.33 | -8.416 | -8.192 | -7.895 | -5.86 | -5.031 | -3.802 | -3.99 | -2.065 | -3.08 | -0.524 | -0.524 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | -5.772 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.199 | 2.417 | 2.677 | 2.984 | 2.26 | 2.22 | 1.403 | 1.102 | 0.61 | 0.351 | 0.15 | 0.053 | 0.005 | 0.003 | 0.006 | 0.01 | 0.021 | 0.023 | 0.04 | 0.41 | 0.457 | 0.381 | 0.444 | 0.458 | 0.16 | -6.196 | 0.014 | 0.014 |
| Income Before Tax
| -32.586 | -30.629 | -27.602 | -25.047 | -20.886 | -16.448 | -14.487 | -15.854 | -15.692 | -11.427 | -12.91 | -12.946 | -13.888 | -11.56 | -11.139 | -9.702 | -9.309 | -8.393 | -8.152 | -7.485 | -5.403 | -4.65 | -3.358 | -3.532 | -1.905 | -9.276 | -0.511 | -0.511 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | -5.208 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0.35 | 1.457 | -0.355 | 0.248 | 0 | -0.813 | -0.351 | -0.15 | -0.053 | -0.234 | 0 | 0 | 0 | -0.11 | 0 | 0 | 0 | -0.051 | 0 | 0 | -3.99 | -2.065 | -3.128 | 0.014 | 0.014 |
| Net Income
| -32.586 | -30.629 | -27.602 | -25.047 | -20.886 | -16.448 | -14.487 | -15.854 | -14.879 | -11.076 | -12.76 | -12.893 | -13.888 | -11.56 | -11.139 | -9.702 | -9.309 | -8.393 | -8.152 | -7.485 | -5.403 | -4.65 | -3.358 | -3.532 | -1.905 | -9.276 | -0.511 | -0.511 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | -5.208 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.65 | -0.63 | -0.56 | -0.51 | -0.47 | -0.37 | -0.37 | -0.45 | -0.51 | -0.38 | -0.44 | -0.45 | -0.49 | -0.45 | -0.55 | -0.51 | -0.4 | -0.36 | -0.35 | -0.33 | -0.22 | -0.21 | -0.23 | -0.24 | -0.52 | -0.64 | -0.22 | -0.22 |
| EPS Diluted
| -0.65 | -0.62 | -0.56 | -0.51 | -0.47 | -0.37 | -0.37 | -0.42 | -0.51 | -0.38 | -0.44 | -0.45 | -0.49 | -0.45 | -0.45 | -0.41 | -0.4 | -0.36 | -0.35 | -0.33 | -0.22 | -0.21 | -0.23 | -0.24 | -0.52 | -0.64 | -0.22 | -0.22 |
| EBITDA
| -23.292 | -32.622 | -29.853 | -27.638 | -22.81 | -18.313 | -15.52 | -16.591 | -15.944 | -11.415 | -12.822 | -12.78 | -13.659 | -11.342 | -10.983 | -9.596 | -9.22 | -8.326 | -8.114 | -7.819 | -5.809 | -4.999 | -3.781 | 0 | 0 | 0 | 0 | 0 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | -5.688 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |